JMDC Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
2,819
- Stock Symbol
-
4483
- Investments
-
14
- Share Price
-
$24.10
- (As of Thursday Closing)
JMDC General Information
Description
JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies. The company operates in two segments namely, Health Big Data that collects, manages, and analyzes medical claims, prescription, and health examination data to support pharmaceutical companies, insurers, and research organizations with data-driven insights. Telemedicine segment which offers remote diagnostic imaging matching services and digital infrastructure that enable medical institutions to conduct efficient remote image interpretation and consultations.
Contact Information
Website
www.jmdc.co.jpCorporate Office
- 12th Floor, Sumitomo Shiba Daimon Building
- 2-5-5 Shibadaimon, Minato-ku
- Tokyo, 105-0012
- Japan
Corporate Office
- 12th Floor, Sumitomo Shiba Daimon Building
- 2-5-5 Shibadaimon, Minato-ku
- Tokyo, 105-0012
- Japan
JMDC Stock Performance
As of 12-Nov-2026, JMDC’s stock price is $24.10. Its current market cap is $1.58B with 65.5M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $24.10 | $25.04 | $15.07 - $29.28 | $1.58B | 65.5M | 307K | $0.71 |
JMDC Financials Summary
As of 30-Sep-2026, JMDC has a trailing 12-month revenue of $349M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,596,712 | 1,458,829 | 1,326,418 | 1,561,025 |
| Revenue | 349,166 | 334,795 | 273,590 | 211,586 |
| EBITDA | 92,468 | 91,040 | 75,503 | 53,443 |
| Net Income | 46,638 | 44,883 | 47,706 | 31,885 |
| Total Assets | 1,007,591 | 991,743 | 955,745 | 809,065 |
| Total Debt | 321,600 | 325,576 | 313,334 | 249,957 |
JMDC Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
JMDC Patents
JMDC Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7858124-B1 | Information processing device, information processing method, and program | Active | 23-Dec-2025 | ||
| JP-7930680-B1 | Information processing systems, information processing methods, and programs | Active | 20-Sep-2025 | ||
| JP-2026110204-A | Information processing device, information processing method, and program for predicting fracture risk | Active | 20-Dec-2024 | ||
| JP-7741285-B1 | Information processing device, information processing method, and program for predicting fracture risk | Active | 20-Dec-2024 | ||
| JP-7785906-B1 | Information processing system, information processing method and program | Active | 20-Dec-2024 |
JMDC Signals
JMDC Investments & Acquisitions (14)
JMDC’s most recent deal was a Merger/Acquisition with Cancer Scan for . The deal was made on 31-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cancer Scan | 31-Jan-2024 | Merger/Acquisition | Other Healthcare Services | ||
| Real World Data | 12-Jul-2022 | Merger/Acquisition | Medical Records Systems | ||
| SEEDSUPPLY | 01-Apr-2022 | Merger/Acquisition | Drug Discovery | ||
| ClinCloud | 01-Jan-2022 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Antaa | 31-Aug-2021 | Merger/Acquisition | Other Healthcare Technology Systems |
JMDC ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
23.53 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Health Care IT Services
Subindustry
of 50
Rank
Percentile
JMDC Exits (2)
JMDC’s most recent exit was on 01-Jan-2022 from ClinCloud. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| ClinCloud | 01-Jan-2022 | Completed |
|
||
| Heartseed | 11-Mar-2020 | Later Stage VC | Completed |
|
JMDC Affiliates
Subsidiaries (11)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Flixy (Clinics/Outpatient Services) | Sumida-ku, Japan | 2016 | |
| Antaa | Tokyo, Japan | 2016 | |
| Real World Data | Kyoto, Japan | 2015 | |
| Cotree | Tokyo, Japan | 2014 | |
| Mecompany | Tokyo, Japan | 2010 |
JMDC FAQs
-
When was JMDC founded?
JMDC was founded in 2002.
-
Where is JMDC headquartered?
JMDC is headquartered in Tokyo, Japan.
-
What is the size of JMDC?
JMDC has 2,819 total employees.
-
What industry is JMDC in?
JMDC’s primary industry is Other Healthcare Services.
-
Is JMDC a private or public company?
JMDC is a Public company.
-
What is JMDC’s stock symbol?
The ticker symbol for JMDC is 4483.
-
What is the current stock price of JMDC?
As of 12-Nov-2026 the stock price of JMDC is $24.10.
-
What is the current market cap of JMDC?
The current market capitalization of JMDC is $1.58B.
-
What is JMDC’s current revenue?
The trailing twelve month revenue for JMDC is $349M.
-
What is JMDC’s annual earnings per share (EPS)?
JMDC’s EPS for 12 months was $0.71.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process